沛嘉医疗-B：Sutra Hemi-valve经导管二尖瓣修复系统第一次应用于人体的临床试验首例植入

Core Viewpoint - Sutra Medical, Inc. has successfully completed the first human implantation of its Sutra Hemi-valve transcatheter mitral valve repair system, indicating a significant advancement in treating severe functional mitral regurgitation in high-risk patients [1] Company Summary - Sutra Medical, Inc. is a company in which the group holds a strategic investment, focusing on innovative medical solutions [1] - The first implantation was performed on an 83-year-old high-risk patient with severe functional mitral regurgitation at Waikato Hospital in New Zealand [1] - The patient had a successful recovery and was discharged three days post-operation, showcasing the potential effectiveness of the Sutra Hemi-valve system [1]